Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis

被引:22
作者
Ke, Yani [1 ]
Liu, Shan [2 ]
Zhang, Zheyuan [3 ]
Hu, Jie [4 ]
机构
[1] Zhejiang Chinese Med Univ, Clin Med Coll 2, 548 Binwen Rd, Hangzhou 310051, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Dept Clin Evaluat Ctr, Affiliated Hosp 1, 54 Youdian Rd, Hangzhou 310006, Zhejiang, Peoples R China
[3] Zhejiang Chinese Med Univ, Clin Med Coll 1, 548 Binwen Rd, Hangzhou 310051, Zhejiang, Peoples R China
[4] Zhejiang Chinese Med Univ, Dept Infect Dis, Affiliated Hosp 1, 54 Youdian Rd, Hangzhou 310006, Zhejiang, Peoples R China
关键词
Metabolic-associated fatty liver disease; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Angiopoietin-like proteins; Angiopoietin-like protein 8; Meta-analysis; LIPOPROTEIN-LIPASE; LIPID-METABOLISM; BETATROPHIN; TARGETS; ANGPTL8; NAFLD;
D O I
10.1186/s12944-021-01481-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Angiopoietin-like proteins (ANGPTLs) are closely related to insulin resistance and lipid metabolism, and may be a key in metabolic syndrome. Non-alcoholic fatty liver disease (NAFLD) (newly named metabolicassociated fatty liver disease (MAFLD)) is based on metabolic dysfunction. There may be some correlation between ANGPTLs and MAFLD, but the specific correlation is unclear. This study aims to explore the predictive role of ANGP TLs in MAFLD and its progression. Methods: Seven databases (PubMed, EMBASE, Cochrane Library, CNKI, WANFANG, CBM and Clinicaltrials.gov) were searched with free terms and MeSH terms. The random-effects model was used to pool the data, and Standardized Mean Difference (SMD) and 95% confidence intervals (CI) were taken as the overall outcome. No language restrictions existed in the article selection. RevMan 5.3, Stata 16 and MetaXL software were applied to analyse the data and the GRADE system was utilized to assess the certainty of evidence. Results: After reviewing 823 related articles, 13 studies (854 cases and 610 controls) met the inclusion criteria, and contributed to this meta-analysis. The results showed that circulating ANGPTL8 level was significantly elevated in the MAFLD group than in the healthy control group (SMD = 0.97 pg/mL, 95%CI: 0.77, 1.18). Conversely, there was no significant difference in the ANGPTL4 (SMD = 0.11 ng/mL, 95%CI: - 0.32, 0.54) and ANGPTL3 (SMD = - 0.95 ng/ mL, 95%CI: - 4.38, 2.48) between the two groups. Subgroup analysis showed that: 1) the MAFLD group had significantly higher ANGPTL8 levels than the healthy control group in Asian and other races; 2) the ANGPTL8 levels in Body Mass Index (BMI) > 25 kg/m(2) patients with MAFLD were higher than those in the healthy control group; 3) the higher ANGPTL8 levels were observed in moderate to severe MAFLD group than the healthy control group. Meta-regression demonstrated that BMI might effectively explain the high heterogeneity. No significant publication bias existed (P > 0.05). The certainty of evidence was assessed as very low by the GRADE system. Conclusions: The ANGPTLs may be related to MAFLD. The increased ANGPTL8 level may be positively correlated with different situations of MAFLD, which may act as a potential indicator to monitor the development trends.
引用
收藏
页数:15
相关论文
共 48 条
[1]   The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation [J].
Abu-Farha, Mohamed ;
Ghosh, Anindya ;
Al-Khairi, Irina ;
Madiraju, S. R. Murthy ;
Abubaker, Jehad ;
Prentki, Marc .
PROGRESS IN LIPID RESEARCH, 2020, 80
[2]   Serum Angiopoietin-like peptide 4 levels in patients with hepatic steatosis [J].
Altun, Ozgur ;
Dikker, Okan ;
Arman, Yucel ;
Ugurlukisi, Bilal ;
Kutlu, Orkide ;
Cil, Eylem Ozgun ;
Yoldemir, Sengul Aydin ;
Akarsu, Murat ;
Ozcan, Mustafa ;
Kalyon, Semih ;
Ozsoy, Neslihan ;
Tukek, Tufan .
CYTOKINE, 2018, 111 :496-499
[3]   Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease [J].
Anstee, Quentin M. ;
Mantovani, Alessandro ;
Tilg, Herbert ;
Targher, Giovanni .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (07) :425-439
[4]   Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters [J].
Cobbina, Enoch ;
Akhlaghi, Fatemeh .
DRUG METABOLISM REVIEWS, 2017, 49 (02) :197-211
[5]   Can targeting ANGPTL proteins improve glucose tolerance? [J].
Davies, Brandon S. J. .
DIABETOLOGIA, 2018, 61 (06) :1277-1281
[6]  
Deeks JJ, 2021, Cochrane Handbook for Systematic Reviews of Interventions Version 6
[7]  
Dijk W, 2016, J LIPID RES, V57, P1670, DOI 10.1194/jlr.M067363
[8]   Regulation of lipid metabolism by angiopoietin-like proteins [J].
Dijk, Wieneke ;
Kersten, Sander .
CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) :249-256
[9]   The association of angiopoietin-like peptide 4 levels with obesity and hepatosteatosis in adolescents [J].
Dikker, Okan ;
Dag, Nevin Cetin ;
Sahin, Mustafa ;
Turkkan, Emine ;
Dag, Huseyin .
CYTOKINE, 2020, 125
[10]   Advances in the meta-analysis of heterogeneous clinical trials II: The quality effects model [J].
Doi, Suhail A. R. ;
Barendregt, Jan J. ;
Khan, Shahjahan ;
Thalib, Lukman ;
Williams, Gail M. .
CONTEMPORARY CLINICAL TRIALS, 2015, 45 :123-129